Camp4
3 known investors
Camp4 is a biotechnology company focused on genetic research and neurology, leveraging expertise in genomics and neuroscience for therapeutic development.
Founders & leadership
CW
Christopher Walsh, MD, PhDScientific Advisor
Investors · 3
In the news
- We Think Camp4 Therapeutics (NASDAQ:CAMP) Can Afford To Drive Business Growth - Simply Wall St Newssimplywall.st · 2026
- Camp4 Raises $100M in Series B Financingfinsmes.com · 2022